Home Capital Investing ideas

UOB Asset Management bets on recovery from successful vaccine rollout

Jovi Ho
Jovi Ho2/10/2021 06:30 AM GMT+08  • 7 min read
UOB Asset Management bets on recovery from successful vaccine rollout
“I’ve been in finance since 1990. I’ve never seen economic devastation like what we saw last year.”
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

The impact of Covid-19 on the global economy last year took even veterans of the finance sector by surprise. “I’ve been in finance since 1990,” says Anthony Raza, senior director and head of multi-asset strategy at UOB Asset Management (UOBAM). “I’ve never seen economic devastation like what we saw last year.”

Yet, optimism is in no short supply. Although the current waves of Covid-19 infections are surpassing prior waves, UOBAM believes the markets are confident for a sharp economic rebound in the wake of lockdowns, and that vaccines will finally quell the pandemic before the end of 2021.

In fact, economic recovery is entirely dependent on how successful countries are with their vaccine rollouts, says UOBAM in its 2021 Investment Outlook Seminar, held recently.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.
Unlock unlimited access to premium articles with less than $9 per month. Subscribe Now